TARGETING THE?aV?3/NgR2 PATHWAY?IN NEUROENDOCRINE PROSTATE CANCER.
Testa A, Quaglia F, Naranjo NM, Verrillo CE, Shields CD, Lin S, Pickles MW, Hamza DF, Von Schalscha T, Cheresh DA, Leiby B, Liu Q, Ding J, Kelly WK, Craig Hooper D, Corey E, Plow EF, Altieri DC, Languino LR. TARGETING THE?aV?3/NgR2 PATHWAY?IN NEUROENDOCRINE PROSTATE CANCER. Matrix Biol. 2023 Nov 11.